Status:
COMPLETED
Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice
Lead Sponsor:
Bayer
Conditions:
Female Contraception
Eligibility:
FEMALE
18-40 years
Brief Summary
MARILIA is a prospective, non-interventional, multicenter study. The purpose of this study is to describe the acceptability of Amenorrhea in contraception indication of Mirena users during one year fo...
Eligibility Criteria
Inclusion
- Age 19-40 years at the time of Mirena IUD insertion
- Using Mirena only for contraception indication
- Never having used the product before
- No heavy menstrual bleeding diagnosed
- Have signed informed consent to participate in this study
Exclusion
- Nulliparous
- Pregnancy
- Mirena's contre-indication
- Mirena for HMB
- Abnormal bleeding pattern
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01833793
Start Date
February 1 2013
End Date
May 1 2015
Last Update
September 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Algeria